Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Adaptive Biotechnologies Corp Director's Dealing 2020

Jan 8, 2020

31660_dirs_2020-01-07_d76a3708-f061-4e54-a33f-8b0f9fc22d04.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2019-12-31

Reporting Person: LO FRANCIS (Chief People Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-07-01 Common Stock P 2500 $20.00 Acquired 2500 Indirect